- Trials with a EudraCT protocol (285)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
285 result(s) found for: Psychiatric Care.
Displaying page 1 of 15.
EudraCT Number: 2013-003219-22 | Sponsor Protocol Number: LMS/SF/UH/0018 | Start Date*: 2014-01-27 | |||||||||||
Sponsor Name:Hertfordshire Partnership University NHS Foundation Trust [...] | |||||||||||||
Full Title: A randomised controlled feasibility trial comparing clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination i... | |||||||||||||
Medical condition: Obsessive Compulsive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004460-63 | Sponsor Protocol Number: EXPO | Start Date*: 2019-07-01 | ||||||||||||||||
Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | ||||||||||||||||||
Full Title: Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): An Open Label Randomised Controlled Trial of Injectable Depot Maintenance Buprenorphine versus Standard-Of-Care Oral Maintenance Opi... | ||||||||||||||||||
Medical condition: Opiod addiction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004688-30 | Sponsor Protocol Number: 15892A | Start Date*: 2014-05-19 | ||||||||||||||||
Sponsor Name:H. Lundbeck A/S | ||||||||||||||||||
Full Title: Interventional, open-label study of 18 mg Selincro® as needed use, in the treatment of patients with alcohol dependence in primary care | ||||||||||||||||||
Medical condition: Alcohol Dependency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-001064-30 | Sponsor Protocol Number: ACP-103-050 | Start Date*: 2018-12-12 | ||||||||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | ||||||||||||||||||
Full Title: A Phase 1, Open Label, Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Pimavanserin in Adolescents with Psychiatric Disorders | ||||||||||||||||||
Medical condition: Psychiatric Disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000202-49 | Sponsor Protocol Number: CN138-134 | Start Date*: 2005-02-22 |
Sponsor Name:Bristol-Myers Squibb International Corporation | ||
Full Title: Efficacy of Aripiprazole in Combination with Valproate or Lithium in the Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy Revised... | ||
Medical condition: Bipolar disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: EE (Completed) HU (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000039-16 | Sponsor Protocol Number: LUMC-PHEG-20172022 | Start Date*: 2017-10-10 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Paracetamol to enhance quality of life and daily function and to decrease care dependency in advanced dementia: A randomized, double-blind, placebo-controlled crossover trial in long-term care faci... | |||||||||||||
Medical condition: We will investigate the effect of regularly scheduled administration of paracetamol on Quality of life, daily functioning, care dependency, pain, change in challenging behaviour and antipsychotic m... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002471-18 | Sponsor Protocol Number: | Start Date*: 2019-01-18 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: The clinical effectiveness and cost effectiveness of clozapine for inpatients with borderline personality disorder: randomised controlled trial | |||||||||||||
Medical condition: Borderline Personality Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000043-74 | Sponsor Protocol Number: PNAS0122 | Start Date*: 2023-07-27 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Defining and predicting neonatal inadaptation after gestational exposure to antidepressants: longitudinal exploratory analysis of psychoneuroendocrine risk factors and complications | ||
Medical condition: major depressive disorder poor neonatal adaptation syndrome (after antidepressant use during pregnancy) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003850-26 | Sponsor Protocol Number: 31-11-284 | Start Date*: 2012-01-30 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with Aripiprazole IM Depot Compared with 6-month Retrospectiv... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002859-19 | Sponsor Protocol Number: 072016 | Start Date*: 2017-08-22 |
Sponsor Name:Erasmus MC | ||
Full Title: Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail? | ||
Medical condition: People with challenging behavior and off-label antipsychotic use | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001518-40 | Sponsor Protocol Number: 848040001 | Start Date*: 2020-01-31 |
Sponsor Name:VU Medical Center | ||
Full Title: Netherlands study of Optimal, PERsonalized Antidepressant use (OPERA-DISCONTINUATION) | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004705-59 | Sponsor Protocol Number: 406201215432 | Start Date*: 2013-12-17 |
Sponsor Name:Hôpital Erasme, ULB | ||
Full Title: Monocentric phase III clinical trial using citalopram (antidepressive compound fequently used in clinic) added to the standard of care (radio- combined with temozolomide chemotherapy and followed b... | ||
Medical condition: Newly diagnosed glioblastoma (primary highly malignant brain cancer) patients Under treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004422-42 | Sponsor Protocol Number: ESKETINSUI2002 | Start Date*: 2017-10-02 | ||||||||||||||||||||||||||
Sponsor Name:Janssen-Cilag International NV | ||||||||||||||||||||||||||||
Full Title: A Double-blind, Randomized, Psychoactive Placebo-controlled, Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine in Addition to Comprehensiv... | ||||||||||||||||||||||||||||
Medical condition: Major Depressive Disorder with Imminent Risk of Suicide | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Completed) ES (Restarted) BE (Completed) PL (Completed) IT (Completed) BG (Completed) FR (Completed) Outside EU/EEA | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-024371-12 | Sponsor Protocol Number: CN162-010 | Start Date*: 2011-11-15 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A multicenter, Double-blind 58 week Rollover Study to assess the Safety and Tolerability of BMS-820836 in Patients with Treatment Resistant Major Depression. | |||||||||||||
Medical condition: Subjects with Treatment Resistant Major Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Temporarily Halted) SE (Completed) FI (Prematurely Ended) AT (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001529-24 | Sponsor Protocol Number: 190-062 | Start Date*: 2007-03-06 | |||||||||||
Sponsor Name:Sepracor NV in care of Sepracor Inc. | |||||||||||||
Full Title: Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit... | |||||||||||||
Medical condition: Insomnia Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) SE (Completed) GB (Completed) FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003992-23 | Sponsor Protocol Number: 54135419SUI3002 | Start Date*: 2017-07-26 | ||||||||||||||||||||||||||
Sponsor Name:Janssen-Cilag International NV | ||||||||||||||||||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Sympto... | ||||||||||||||||||||||||||||
Medical condition: Major Depressive Disorder with Imminent Risk of Suicide | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: BE (Completed) PL (Completed) CZ (Completed) AT (Completed) LT (Completed) FR (Completed) ES (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008896-32 | Sponsor Protocol Number: MACS(Uni-Koeln-1260) | Start Date*: 2010-12-22 |
Sponsor Name:University of Cologne | ||
Full Title: Memory, Ageing, and the Cholinergic System a combined fMRI and PET study | ||
Medical condition: Patients with mild cognitive impairment (MCI) (50-80 years), who are at greater risk of developing alzheimer's dementia will be recruited in the present study and will be compared to an age-matched... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-000618-32 | Sponsor Protocol Number: GNC-501 | Start Date*: 2022-09-29 | ||||||||||||||||
Sponsor Name:GENEURO SA | ||||||||||||||||||
Full Title: Temelimab as a Disease Modifying Therapy in Patients with Neurological, Neuropsychological, and Psychiatric (=Neuropsychiatric) Symptoms in Post-COVID-19 or Postacute Sequelae of COVID-19 (PASC) Sy... | ||||||||||||||||||
Medical condition: Postacute Sequelae of COVID-19 (PASC) Syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002492-29 | Sponsor Protocol Number: 1928376455 | Start Date*: 2014-10-10 | |||||||||||||||||||||
Sponsor Name:Department of anaesthesia and intensive care, Hvidovre Hospital | |||||||||||||||||||||||
Full Title: The effect of Single-Dose Glucocorticoid on Postoperative delirium among Elderly Hip Fracture Patientes: A Randomized Placebo Controlled Study | |||||||||||||||||||||||
Medical condition: Postoperative Delirium | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003825-27 | Sponsor Protocol Number: 263CS201 | Start Date*: 2020-06-02 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.